Repare Therapeutics’ (RPTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) in a research report sent to investors on Monday, Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Repare Therapeutics’ Q4 2023 earnings at $0.02 EPS, FY2023 earnings at ($1.55) […]
More Stories
Education Department Promotes Patriotic School Curriculum
By Aaron Gifford Department of Education Secretary Linda McMahon this week announced “a landmark initiative” for promoting the instruction of...
Shares of Intel Increase 30 Percent on $5 Billion Nvidia Investment
By Andrew Moran Shares of Intel increased by about 30 percent at the opening bell after Nvidia announced a $5...
US Weekly Jobless Claims Fall to 1-Month Low After Sharp Decline
By Andrew Moran Employment data continue to send mixed signals about labor market conditions as the number of Americans filing...
Solo Leveling Season 3: Releasing Date is Earlier than You Expected!
Solo Leveling, also called Only I Level Up, is an anime TV series. This is a Korean series based on...
Exxon Mobil Corporation $XOM Shares Bought by Balefire LLC
Balefire LLC grew its holdings in shares of Exxon Mobil Corporation (NYSE:XOM – Free Report) by 101.2% during the second...
Fiduciary Alliance LLC Has $980,000 Stock Holdings in GE Aerospace $GE
Fiduciary Alliance LLC lifted its stake in GE Aerospace (NYSE:GE – Free Report) by 51.4% during the second quarter, according...